Close

Geovax Labs Inc. (GOVX) Reports Publication of COH04S1, Showing it Produced Robust Antibodies and T cells Against SARS-CoV-2 Mar 10, 2022 09:07AM
Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2 Mar 10, 2022 09:00AM
GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope's COVID-19 Vaccine Nov 9, 2021 04:00PM